Antidote

JANUARY 29, 2024

For individuals living with a condition like melanoma, volunteering to participate in a clinical trial can be a rewarding experience. Not only will patients be able to gain access to potential new treatments, but they will also be directly contributing to research that can save lives — something that Jamie Troil Goldfarb has experienced firsthand. Jamie received a diagnosis of stage IV melanoma in 2011, only 11 weeks after giving birth to her child.

Clinical Trials 122

Clinical Trials Clinical Trials Trials Doctor 122

Pharmaceutical Technology

JANUARY 29, 2024

The upcoming OCT West Coast 2024 conference will feature experts talking about emerging techologies, clinical trial operations for pharma and medical devices, and patient participation in studies.

Clinical Trials 130

Clinical Trials Clinical Trials Trials 130

Antidote

JANUARY 30, 2024

Facilitating medical research relies on patient participation, yet research protocols often overlook the patient perspective. Improving patient centricity in clinical trials demands prioritizing the patient experience.

Clinical Trials 90

Clinical Trials Clinical Trials Trials Research 90

Pharmaceutical Commerce

JANUARY 31, 2024

Including patient and family feedback in our discussions will help shape our understanding of their perception of provided care and services and how we operate as a whole.

52

52

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Medicine

Pharmaceutical Technology

JANUARY 30, 2024

Setting up trial sites in countries with unmet clinical needs can lead to higher patient recruitment, compared to established trial hubs.

Trials 130

Trials 130

pharmaphorum

JANUARY 31, 2024

Reverba offers innovative patient engagement solutions and strategies that utilise the power of authentic patient influencers. Discover the secret to successful patient influencer marketing and how it can benefit your healthcare organisation.

Marketing 118

Marketing 118

BioPharma Reporter

JANUARY 30, 2024

Merck has signed a R&D collaboration deal with data and technology company Culmination Bio, a spinoff from Intermountain Health.

Research 85

Research Regulation Marketing 85

WCG Clinical

JANUARY 31, 2024

Site-Enablement-Infographic Download Benchmark site performance for your study Interested to see how the investigators in your current or planned studies match up against the historic performance of all available investigators for the therapeutic area of the study? Complete the form to schedule a consultation with WCG. We’ll share benchmark data from the WCG Knowledge Base, analyze your results, and share some of the common practices of top performers.

Clinical Trials 52

Clinical Trials Clinical Trials Trials 52

Pharmaceutical Technology

JANUARY 29, 2024

At the JP Morgan Healthcare conference, Merck (MSD) indicated its eagerness to continue to establish its place in the immunological space.

362

362

Bio Pharma Dive

JANUARY 30, 2024

Since a landmark paper in 2022, drugmakers have begun nearly a dozen trials of cell therapies for lupus, with more set to start. Here’s why their efforts are worth watching.

Trials 354

Trials 354

Advertisement

Clinical Supply

Rethinking Clinical Trials

JANUARY 31, 2024

In this Friday's PCT Grand Rounds, Susan Winckler of the Reagan-Udall Foundation for the FDA will present "Strategies for Improving Public Understanding of FDA and the Products It Regulates: Why Should We Care, and What Might We Do?" The Grand Rounds session will be held on Friday, February 2, 2024, at 1:00 pm eastern. Winckler is the chief executive officer of the Reagan-Udall Foundation for the FDA, a nonprofit organization created by Congress “to advance the mission of the FDA to modernize me

Cosmetics 162

Cosmetics Clinical Trials Clinical Trials Production 162

Pharma Times

FEBRUARY 2, 2024

Dopamine neuron senescence is a hallmark of Parkinson’s disease

Medicine 155

Medicine 155

Pharmaceutical Technology

JANUARY 29, 2024

The rapid sequencing of the SARS-CoV-2 and the subsequent development of mRNA vaccines led to the authorisation of the first of these vaccines in late 2020.

Vaccine 278

Vaccine Vaccination Development 278

Bio Pharma Dive

JANUARY 30, 2024

The company plans to soon ask the FDA for approval of the drug, which it has pitched as a safer alternative to addictive opioid painkillers.

Drugs 340

Drugs Trials 340

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

pharmaphorum

JANUARY 31, 2024

Novartis ends development of Tim3 antibody sabatolimab in myelodysplastic syndromes after failed phase 3 trial.

Antibody 137

Antibody Drugs Trials Development 137

Pharma Times

FEBRUARY 1, 2024

Tumours with high mtDNA mutations more likely to respond to Opdivo

Drugs 148

Drugs DNA Research 148

Pharmaceutical Technology

JANUARY 30, 2024

The EMA has accepted GSK’s regulatory application seeking expansion of its RSVvaccine, Arexvy, to include adults aged 50 to 59 years.

Vaccine 264

Vaccine Vaccination 264

Bio Pharma Dive

FEBRUARY 2, 2024

The California biotech is the third this year to go public, following stock offerings from CG Oncology and Arrivent Biopharma.

Development 328

Development Drugs 328

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Fierce Pharma

JANUARY 29, 2024

The start of the new year doesn’t seem to have dulled the zeal of Pfizer’s global cost-cutting campaign, which has already left hundreds of jobs in its wake. | Come mid-February, Pfizer will lay off some 52 employees at a facility in South San Francisco, according to a recent Worker Adjustment and Retraining Notification Act alert. The site is the former headquarters of Global Blood Therapeutics.

137

137

Pharma Times

JANUARY 30, 2024

Type 2 diabetes is estimated to affect 462 million people worldwide

147

147

Pharmaceutical Technology

FEBRUARY 1, 2024

Merck & Co (MSD) has reported a 1% revenue increase from 2022, and may face setbacks in the next few years from top-selling drugs.

Drugs 262

Drugs 262

Bio Pharma Dive

JANUARY 29, 2024

The FDA is reviewing the companies’ application for a “tumor agnostic” indication for their drug Enhertu, which would break new ground for antibody-drug conjugates.

Antibody 314

Antibody Drugs 314

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

Clinical Research

Rethinking Clinical Trials

JANUARY 31, 2024

           Speakers Mark Sendak, MD, MPP Population Health & Data Science lead Duke Institute for Health Innovation (DIHI) Suresh Balu, MD, MBA Director, Duke Institute for Health Innovation (DIHI) Associate Dean, Innovation and Partnership Duke School of Medicine Slides Keywords AI, ML, health equity Key Points The Duke Institute for Health Innovation’s (DIHI) mission is to catalyze transformative innovation in health and healthcare through high-impact research, leadership develo

Production 133

Production Development Clinical Trials Clinical Trials 133

Pharma Times

FEBRUARY 1, 2024

Prescriptions ordered via the app are expected to save around 1.

132

132

Pharmaceutical Technology

JANUARY 29, 2024

An eye-catching milestone in hand, Ascidian will begin the Phase I/II STELLAR study of ACDN-01 for Stargardt disease in H1 2024.

RNA 261

RNA Gene Therapy Gene 261

Bio Pharma Dive

FEBRUARY 1, 2024

Roche said it was shelving those drugs in favor of experimental programs to treat obesity that it gained from its takeover of Carmot Therapeutics.

Drugs 310

Drugs 310

Advertisement

Clinical Supply

Fierce Pharma

FEBRUARY 2, 2024

Mark your calendars, oncology drug and CAR-T therapy developers. | Mark your calendars, oncology drug and CAR-T therapy developers. The FDA has decided on a date for a highly anticipated advisory committee meeting for Bristol Myers' Abecma and J&J's Carvykti.

Development 131

Development Drugs 131

pharmaphorum

FEBRUARY 1, 2024

Hybrid and multi-cloud: The next step for biotech to secure flexible, scalable scientific workflows Mike.

129

129

Pharmaceutical Technology

JANUARY 29, 2024

The EMA CHMP has recommended marketing authorisation for Bristol Myers Squibb’s Abecma for multiple myeloma.

Marketing 261

Marketing 261

Bio Pharma Dive

JANUARY 30, 2024

Roche, Pfizer and Bristol Myers Squibb have all invested in the startup, which is using nanoparticle technology to retrain the body’s immune system.

305

305

Advertisement

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

Clinical Trials